BioStem Technologies, Inc. (BSEM)
3.71
+0.10
(+2.77%)
USD |
NASDAQ |
Sep 04, 16:00
3.78
+0.07
(+1.89%)
After-Hours: 20:00
BioStem Technologies Research and Development Expense (Quarterly) : 0.7336M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7336M |
| March 31, 2026 | 1.137M |
| December 31, 2025 | 1.481M |
| September 30, 2025 | 1.958M |
| June 30, 2025 | 1.957M |
| March 31, 2025 | 1.690M |
| December 31, 2024 | 1.273M |
| September 30, 2024 | 0.4889M |
| June 30, 2024 | 0.0852M |
| March 31, 2024 | 0.0707M |
| December 31, 2023 | 0.342M |
| September 30, 2023 | 0.0375M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0609M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.0176M |
| September 30, 2021 | 0.1021M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.0295M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 3.303M |
| CorMedix, Inc. | 6.684M |
| Eloxx Pharmaceuticals, Inc. | 2.84M |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.0041M |